Copd NewsNews on Copd continually updated from thousands of sources around the net.BioMarck Initiates Phase 2 Clinical Study of COPD Treatment- June 30, 2008 RESEARCH TRIANGLE PARK, N.C. BioMarck Pharmaceuticals, Ltd. announced today that it has initiated the Phase 2 clinical development program of BIO-11006 Inhalation Solution, a novel treatment for chronic ...http://www.topix.net/health/copd/2008/06/biomarck-initiates-phase-2-clinical-study-of-copd... Nycomed Canada Solidifies Leadership Position in the Canadian Respiratory Market- June 27, 2008 Nycomed Canada Inc. today announced a licensing agreement with Chiesi Farmaceutici SpA to market Atimos , a treatment anticipated to be indicated for asthma and Chronic Obstructive Pulmonary Disease .http://www.topix.net/health/copd/2008/06/nycomed-canada-solidifies-leadership-position-in-... New Hope For COPD Patients In Mucolytic Carbocisteine- June 15, 2008 Editor's Choice Main Category: Respiratory Asthma Also Included In: Clinical Trials Drug Trials Article Date: 14 Jun 2008 - 0:00 PDT The worsening of symptoms in patients with chronic obstructive pulmonary ...http://www.topix.net/health/copd/2008/06/new-hope-for-copd-patients-in-mucolytic-carbocist... Anti-Mucus Drug Slows Symptoms of COPD- June 13, 2008 In people suffering from chronic obstructive pulmonary disease , the expectorant carbocisteine seems to help slow worsening of symptoms, Chinese researchers report.http://www.topix.net/health/copd/2008/06/anti-mucus-drug-slows-symptoms-of-copd?fromrss=1 Tailoring COPD Treatment To Everyday Impact Of Disease Can Help Patients Lead The Lives They Want- June 10, 2008 Main Category: Respiratory Asthma Article Date: 10 Jun 2008 - 3:00 PDT Leading UK experts in chronic obstructive pulmonary disease are calling for healthcare professionals to place greater emphasis on the ...http://www.topix.net/health/copd/2008/06/tailoring-copd-treatment-to-everyday-impact-of-di... Astra seeks US approval for Symbicort- June 6, 2008 Drug maker AstraZeneca PLC said Wednesday it has applied for U.S. approval to market its asthma treatment Symbicort for children aged 6 to 11.http://www.topix.net/health/copd/2008/06/astra-seeks-us-approval-for-symbicort?fromrss=1 DATAMONITOR: Inhaler devices are still a major hurdle in ast...- June 4, 2008 RDATE:04062008 London -- Although the inhaled delivery of drugs has major advantages over other methods of administration, inhaler devices are often difficult to use and can indirectly have a negative impact on ...http://www.topix.net/health/copd/2008/06/datamonitor-inhaler-devices-are-still-a-major-hur... |